iTeos Therapeutics Inc (ITOS) stock is down -53.50% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives ITOS stock a score of 26 out of a possible 100.
That rank is primarily influenced by a long-term technical score of 2. ITOS's rank also includes a short-term technical score of 4.
ITOS has an Overall Score of 26. Find out what this means to you and get the rest of the rankings on ITOS!
iTeos Therapeutics Inc (ITOS) stock is lower by -8.02% while the S&P 500 is down -0.17% as of 10:08 AM on Thursday, Oct 12. ITOS is down -$0.73 from the previous closing price of $9.16 on volume of 248,883 shares. Over the past year the S&P 500 is up 22.16% while ITOS is down -53.50%. ITOS lost -$0.82 per share in the over the last 12 months.
Click Here to get the full Stock Report for iTeos Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
